Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales... Show more
ONC is expected to report earnings to rise 110.29% to 35 cents per share on November 06
Q3'25
Est.
$0.36
Q2'25
Missed
by $0.04
Q1'25
Beat
by $1.65
Q4'24
Missed
by $0.42
Q3'24
Beat
by $0.95
The last earnings report on August 06 showed earnings per share of 17 cents, missing the estimate of 20 cents. With 65.16K shares outstanding, the current market capitalization sits at 37.23B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ONC showed earnings on August 06, 2025. You can read more about the earnings report here.